Outbreak caused by tobramycin-resistant Pseudomonas aeruginosa in a bone marrow transplantation unit

O Lyytikäinen1, V Golovanova, E Kolho

  • 1Department of Infectious Disease Epidemiology, National Public Health Institute, Helsinki, Finland.

Insights

A Pseudomonas aeruginosa outbreak in a bone marrow transplant ward was traced to contaminated shower heads. Eradicating the source controlled the outbreak, but infections persisted in the intensive care unit.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Hospital Epidemiology

Background:

  • Tobramycin-resistant Pseudomonas aeruginosa (TRPA) infections previously occurred in an intensive care unit (ICU).
  • An outbreak of TRPA bacteremia occurred in a bone marrow transplantation (BMT) ward between May and August 1995.

Purpose of the Study:

  • To investigate the source and strain relatedness of TRPA isolates during the BMT ward outbreak.
  • To determine if the outbreak was caused by a single or multiple strains of P. aeruginosa.

Main Methods:

  • Pulsed-field gel electrophoresis (PFGE) was used to characterize 102 clinical TRPA isolates and 22 environmental isolates.
  • Isolates were obtained from clinical samples across different hospital units and from the hospital environment, including shower heads.

Main Results:

  • A unique P. aeruginosa fragment pattern was identified in all hematological patients during the BMT ward outbreak.
  • This unique strain was also found in 3 ICU patients prior to the BMT outbreak and in 5 BMT ward shower heads.
  • Control measures targeting the contaminated showers successfully halted the BMT ward outbreak.

Conclusions:

  • Contaminated hospital showers served as the probable environmental source of the TRPA outbreak in the BMT ward.
  • While the BMT outbreak was controlled, endemic TRPA infections continued in the ICU, suggesting a broader or persistent issue.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...